Hormonal regulation of uterine chemokines and immune cells by Park, Dong-Wook & Yang, Kwang-Moon
www.eCERM.org Copyright © 2011. THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE 179
REVIEW
http://dx.doi.org/10.5653/cerm.2011.38.4.179
pISSN 2233-8233 · eISSN 2233-8241
Clin Exp Reprod Med 2011;38(4):179-185
Hormonal regulation of uterine chemokines and 
immune cells
Dong-Wook Park
1, Kwang-Moon Yang
2
1Laboratory of Reproductive Biology and Infertility, 
2Department of Obstetrics and Gynecology, Cheil General Hospital and Women’s Healthcare Center, 
Kwandong University College of Medicine, Seoul, Korea
The ultimate function of the endometrium is to allow the implantation of a blastocyst and to support pregnancy. Cycles of tissue remodeling 
ensure that the endometrium is in a receptive state during the putative ‘implantation window’, the few days of each menstrual cycle when an 
appropriately developed blastocyst may be available to implant in the uterus. A successful pregnancy requires strict temporal regulation of ma-
ternal immune function to accommodate a semi-allogeneic embryo. To preparing immunological tolerance at the onset of implantation, tight 
temporal regulations are required between the immune and endocrine networks. This review will discuss about the action of steroid hormones 
on the human endometrium and particularly their role in regulating the inflammatory processes associated with endometrial receptivity. 
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Introduction
The menstrual cycle of women is precisely controlled by endocrine, 
autocrine and paracrine factors regulating follicular development, 
ovulation, luteinisation, luteolysis, and the growth and differentiation 
of the endometrium. The ultimate function of the endometrium is to 
allow the implantation of a blastocyst and to support pregnancy. The 
human endometrium is a dynamic tissue that undergoes repeat cy-
cles involving sequential proliferation, differentiation, breakdown 
and repair. These cycles of tissue remodeling ensure that the endo-
metrium is in a receptive state during the putative ‘implantation win-
dow’, the few days of each menstrual cycle when an appropriately 
developed blastocyst may be available to implant in the uterus. The 
term ‘endometrial receptivity’ refers to the ability of the uterine lining 
to accept and accommodate a nascent embryo, resulting in a success-
ful pregnancy [1]. 
One of the roles of the immune system is to identify non-self anti-
gens and destroy them. During pregnancy, fetal expressed paternal 
antigens render themselves foreign (non-self), and thus the maternal 
immune system must tolerate the semi-allogeneic fetus to support 
the pregnancy. The term ‘immune tolerance’ has been subjected since 
first recognized by Billingham et al. [2]. Both implantation and men-
struation occur under the control of steroid hormones and are regard-
ed as inflammatory events characterized by leukocyte infiltration and 
increased inflammatory mediator expression in the endometrium [3]. 
The modulation of inflammatory events toward immune tolerance 
in the endometrium by the sex steroid hormones involves a highly 
complex network of inflammatory mediators and immune cells, which 
prepare the endometrium for embryo implantation [4]. 
This review will focus on the actions of steroid hormones on the 
human endometrium and particularly their role in regulating the in-
flammatory processes associated with endometrial receptivity. 
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Uterine mucosal immune environments
Mucosal surfaces are in contact with an environment rich in micro-
organisms. Despite this, they have a low incidence of infection, as 
mucosal host defense mechanisms create a hostile environment for 
potential pathogens, minimize inappropriate microbial load and de-
tect and respond appropriately to pathogen challenges. The uterine 
mucosa is unique amongst other mucosal sites, because it under-
goes regular changes in structure under the influence of sex steroids 
[5]. The seminal plasma introduced during intercourse in the mouse, 
pig and human female reproductive tract has been shown to induce 
local inflammatory changes [6]. A considerable proportion of the 
transforming growth factor (TGF)-β synthesized in male accessory 
glands, particularly the seminal vesicle in rodents and the prostate in 
humans is secreted into the fluids that contribute to the ejaculate [7]. 
The TGF-β are key regulators of several aspects of the immune re-
sponses including lymphocytes, macrophages and dendritic cells [8]. 
TGF-β also promotes conversion of CD16
+ peripheral blood natural 
killer (NK) cells into CD16
- NK cells in vitro [9]. TGF-β derived from sem-
inal plasma may affect the maternal immune response in pregnancy 
through promoting type 2 and/or Th3 immunity to paternal antigens 
from the outset of their introduction to the female [10]. This result in-
dicates that TGF-β may play a pivotal role in maternal immune toler-
ance to the fetal ‘semi-allograft’. Furthermore, implantation and live 
birth rates following IVF treatment are significantly improved when 
women are exposed to semen at the beginning of pregnancy [11]. 
TGF-β is a well-known immune-modulating cytokine with pivotal 
roles in inducing active immune tolerance in peripheral and mucosal 
tissues. It is abundant in seminal plasma and is largely account for 
the immune tolerance activity in uterine mucosa [7]. 
An infection-free environment in the uterus is a crucial for success-
ful implantation and pregnancy. Similar to other mucosal surfaces, 
the female reproductive tract expresses molecules of the innate im-
mune system, which are important in preventing infection [4]. Im-
plantation, and in particular trophoblast invasion of the endometri-
um, represents a breach of the mucosal barrier and thus an increased 
expression of the innate immune molecules may be necessary to en-
sure effective defense against potential infection [12]. In addition, re-
cent data have suggested that Toll-like receptors (TLRs) may be acti-
vated by endogenous ligands produced as a result of tissue damage 
and sterile inflammation [13]. Pattern recognition receptors (PRRs) 
including the TLRs and nuclear oligomerization domain proteins 
(NODs) and effector molecules of the innate immune system such as 
defensins, secretory leukocyte protease inhibitor (SLPI) and elafin are 
present in the endometrium [4]. This is relevant to endometrial phys-
iology as implantation may be considered an example of sterile in-
flammation and production of endogenous ligands may modulate 
the inflammatory response via PRRs [14]. The immune tolerance and 
the innate immunity of the endometrium required for a successful 
implantation are in conflict with each other. This is an area that war-
rants further investigations. 
Hormonal regulation of uterine chemokines
Chemokines are key regulators of cell migration, and in leukocytes 
they alter the expression of cellular adhesion molecules and extra 
cellular matrix (ECM) components that sequentially elicit key chang-
es in the architecture of a cell, allowing migration. The binding of a 
chemokine to its receptor on a specific leukocyte up-regulates the 
expression of adhesion molecules, thus promoting leukocyte adhe-
sion to the endothelium and chemotaxis along a concentration gra-
dient [15]. So far, around 50 chemokines, which bind to 18 different 
chemokine receptors, have been identified in humans. These are 
members of the seven-transmembrane receptor family. Initially, che-
mokines were identified as modulators of the immune response [16]. 
There is clear evidence that sex steroid hormones can directly and/
or indirectly affect the expression of a variety of chemokines during 
the menstrual cycle [17-19]. Among the CC and CXC chemokine fam-
ilies, immunohistochemistry has revealed that endometrial endothe-
lial, epithelial, and stromal cells express CCL4/macrophage inflam-
matory protein (MIP)-1β, CCL5/Regulated upon Activation, Normal T-
cell Expressed, and Secreted (RANTES), CCL7/monocyte chemotactic 
protein (MCP)-3, CCL19/Epstein-Barr-virus-induced molecule 1 ligand 
chemokine (ELC), CCL21/secondary lymphoid tissue chemokine (SLC), 
CXCL9/Monokine Induced by Gamma interferon (Mig) and CXCL10/
Interferon gamma-induced protein (IP)-10, and that their expression 
levels vary depending on the phase of the menstrual cycle, being 
higher in the secretory phase than in the proliferative phase [20]. 
Along with this, several chemokines such as CX3CL1, CCL7, CCL14 and 
CCL4 were up-regulated in the mid-secretory phase endometrium 
and maintained in early pregnancy. These factors were identified as 
chemoattractants for macrophages and NK cells, and accumulate at 
the implantation site. In addition to this, Mokhtar et al. [21] have re-
ported that CXCL14 is likely to be regulated by progesterone in hu-
man endometrium and that it may exert a chemo-attractive effect 
on uNK cells and in part be responsible for their clustering around the 
epithelial glands. Jones et al. [22] have reported that macrophage 
derived chemokine (MDC), MCP-3, fractalkine (FKN), hemofiltrate CC 
chemokine (HCC)-1, HCC-4 and MIP-1β are upregulated in the metri-
um during the implantation window, when they may alter leukocyte 
behaviors.
Chemokines can directly and/or indirectly control the uterine cell 
function and implantation. IFN-γ induced expression of CXCL11 in 
the endometrial epithelial cells and that CXCR3. IFN-γ and CXCL11 in-www.eCERM.org
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duced apoptosis of endometrial epithelial cells in vitro, this data spec-
ulate that embryo-derived IFN-γ kills endometrial epithelial cells via 
chemokine expressions in endometrial cells for implantation [23]. 
Hormonal regulation of uterine immune cells
Tibbetts et al. [24] have suggested that estradiol leads to a pro-in-
flammatory response within the uterus and progesterone creates an 
anti-inflammatory environment by regulating the expression of vari-
ous cytokines. These cytokines (interleukin [IL]-11 and IL-15) also reg-
ulate the process of uterine stromal cells and can affect the prolifera-
tion and differentiation of T helper cells and natural killer (NK) cells 
within the uterus [25,26]. 
It has been proposed that progesterone’s effects on T cells are me-
diated through the blockade of a K
+ channel, which rapidly inhibits 
the Ca
2+ signaling pathway, thus inhibiting production of the major 
proliferative cytokine for T cells [27]. Experimental data have demon-
strated that peripheral blood NK cells (CD56
dimCD16
+), but not CD-
56
brightCD16
- NK cells, express both classical progesterone receptor 
(PR) isoforms (PRA and PRB) and progesterone induces caspase-de-
pendent cell death, which is reversed by two different anti-progestin, 
ZK 98.299 and RU 486, this results supporting the involvement of 
classical PR isoforms (Figure 1) [28]. Furthermore, the lack of PR ex-
pression on CD56
brightCD16
-NK cells provides an additional idea that 
they might represent the PBNK precursors that are selectively recruit-
ed into the endometrium where they differentiate to become the 
uterine NK cells. Additionally, these findings may be relevant to pro-
gesterone and NK cell function in human reproduction in terms of 
immune tolerance. The action of progesterone on endometrium is 
summarized in Figure 2.
Hirano et al. [29] have reported data about estradiol on T cell func-
tion. The authors proposed that 17β-estradiol can enhance NF-κB 
signaling in T cells and thus affect T cell survival. The reproductive im-
munological function of estrogen is still remains to be investigated, 
because estrogen shows a diverse range of functions depending on 
its concentration.
1. Uterine NK cells
NK cells are the predominant lymphocyte population present in 
the uterus [30]. Phenotypic and functional analysis of first trimester 
human decidual CD56
brightCD16
- NK cells indicate that uterine NK (uNK) 
cells are a unique population distinct from the blood counterpart 
(CD56
dimCD16
+), and recent findings have demonstrated that they 
exhibit a unique transcriptional profile [31]. The absolute numbers of 
uNK cells present in the endometrium increases after ovulation al-
though the proportion in relation to other leukocyte subtypes remains 
constant (30%) across the menstrual cycle. It is only when pregnancy 
occurs that this proportion increases to around 70% of the total leu-
kocyte population [32]. It has been reported that chemokines pro-
100
75
50
25
0
P
r
o
g
e
s
t
e
r
o
n
e
 
r
e
c
e
p
t
o
r
 
e
x
p
r
e
s
s
i
o
n
 
l
e
v
e
l
 
(
%
)
T47D
CD56+
CD3+
CD4+
CD20+
B
CD56+PR+  DAPI
A
Figure 1. Presence of progesterone receptor (PR) on peripheral blood natural killer cells by confocal microscopy (A), and flow cytometry (B) (Mo-
dified from Arruvito et al. J Immunol 2008;180:5746-53 [28]). DAPI , 4’,6-diamidino-2-phenylindole. 
Figure 2. Action of progesterone on endometrium in establishment 
and maintenance of pregnancy. NK, natural killer; PIBF, progesterone 
induced blocking factor.
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duced by trophoblast or endometrial cells, such as CXCL9/Mig, CXCL10/ 
IP-10 and CXCL12/SDF-1, or CCL4/MIP-1β and CCL3/MIP-1α can sup-
port the peripheral blood NK cell chemotactic response [33]. 
A large body of evidence indicates that there are different NK cell 
subsets between the peripheral blood and the endometrium (uNK)/
decidua (dNK). Campbell and co-workers have provided the first evi-
dence that distinct (CD56
+CD16
+ and CD56
+CD16
-) peripheral blood 
NK cell subsets have a unique repertoire of chemokine receptors [34]. 
CD16
+ NK cells homogenously express high levels of CXCR1 and CX-
3CR1, low levels of CXCR2 and CXCR3 and no detectable levels of 
CXCR5. In contrast, CD16
- NK cells express high levels of CXCR3, low 
levels of CX3CR1, and are negative for CXCR1, CXCR2, and CXCR5. 
Moreover, both NK cell subsets express high levels of CXCR4, the re-
ceptor for CXCL12/SDF-1α/β. With respect to the CC chemokine re-
ceptor family, these authors found that the majority of NK cells lack 
the expression of CCR1-7 and CCR9, and only the CD16
-NK cell subset 
expresses high levels of CCR5 and CCR7, the latter molecule mainly 
involved in the homing of lymphocytes to secondary lymphoid or-
gans. This evidence indicates that the different NK cell subset popula-
tions in the peripheral blood and uterus arise from the alternating 
chemotactic forces between chemokines and their receptors express-
ed in NK cell subtypes. On the other hand, Keskin et al. [9] have re-
ported that TGF-β can promote conversion of CD16
+ NK cells into 
CD16
- NK cells. Furthermore, it is possible that dNK cells may origi-
nate from precursor cells which residing in uterine tissues or migrate 
there from blood. Park et al. [35] has reported on the coincidence of 
pNK and dNK cell populations. This report indicates that pNK cell po-
pulations negatively correlates with the gestational period of women 
with recurrent miscarriage and have a positive correlation with CD56
+ 
cells in the decidua as well. This data can supports the notion that 
peripheral blood can be a major source of dNK cells. Although a large 
number of experimental results has been reported, the origin of uNK 
and dNK cells has not yet been clearly defined. 
Accumulating evidence indicates that uNK cells contribute to the 
successful implantation and maintenance of pregnancy [36-38]. uNK 
cells exhibit lesser cytotoxic activity as compared with the peripheral 
blood counterpart, although in humans they have been shown to 
express a number of activating receptors including NKG2D, CD244, 
NKp30, NKp44, and NKp46, in human and are endowed with an in-
tact cytolytic machinery, namely perforin, and granzymes [39]. Al-
though uNK cells exhibit poor killing activity, they are capable of se-
creting a wide array of cytokines and chemokines without stimula-
tion, suggesting that they have undergone activation in the decidua 
[40]. uNK cells have ability to produce angiogenic factors such as vas-
cular endothelial growth factor (VEGF), placental growth factor (PlGF), 
and angiopoietin 2 in both mice and humans [36,40]. These results 
have supported the idea that the major role of uNK cells is the con-
trol of decidual angiogenesis and placental development. 
 
2. Uterine mast cells
Mast cells (MCs) have been known to be mediators of allergic reac-
tions, but it has now been recognized that their immune function 
extends far beyond playing critical roles in a variety of non-allergic 
innate [41] and adaptive [42] immune responses. MCs exhibit clear 
tissue-specific phenotypes [43]. Early studies about MCs isolated from 
human myometrium revealed that they share more functional char-
acteristics with lung MCs than skin MCs. For example, uterine MCs re-
sponded to IgE stimulation by releasing of histamine, leukotriene C4 
and prostaglandin (PG) D2 [44]. The number of MCs in the endome-
trium is low, and those are predominantly localized in the basal layer 
[45]. Some evidence indicates that MCs and their products, including 
histamine, may participate in the development of the placenta throu-
gh the regulation of trophoblast invasion and growth. In particular, 
histamine can increase trophoblast expression of αVβ3 integrin, a 
key marker of extravillous trophoblasts [46,47]. Mast cell activation 
and functions can be affected by sex steroid hormones. Zaitsu et al. 
[48] reported that binding of physiological concentrations of estradi-
ol to a membrane estrogen receptor-α on mast cells initiates a rapid 
onset and progressive influx of extracellular Ca
2+, which supports the 
synthesis and release of allergic mediators. Estradiol also enhances 
IgE-dependent mast cell activation, resulting in a shift of the allergen 
dose response. However the trigger for MCs activation and their func-
tions in the implantation needs further investigation.
 
3. Uterine T cells
There is clear evidence to suggest that the maternal T lymphocytes 
at the feto-maternal interface play an important role in fetal survival 
and development. In mice, TH2-type cytokines (IL-4, IL-5, and IL-10) 
are detectable at feto-maternal interface during the period of gesta-
tion, whereas IFN-γ (TH1 cytokine) is transient, being detectable only 
in the first period [49]. Recent studies in mice and humans suggest 
that the production of leukemia inhibitory factor (LIF) in the endo-
metrium is an essential requirement for implantation and embryo 
development [50]. Piccinni et al. [51] have reported that LIF which is 
produced by endometrial epithelial cells, NK cells and T cells is mainly 
produced by TH2-like cells. They also showed that the development 
of LIF-producing T cells is down-regulated by TH1 inducers, IL-12, IFN-α 
and IFN-γ, and up-regulated by IL-4 (TH2 cytokine) and progesterone 
which promote the differentiation of T cells into TH2 effectors. Inter-
estingly, little or no expression of LIF mRNA was seen in the glandular 
epithelium of the decidua, although the adjacent CD45
+ leukocytes 
were strongly positive [52]. Thus, it seems that the production of LIF 
in the decidua could be predominantly attributed to the T cells.
 www.eCERM.org
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4. Uterine dendritic cells
Dendritic cells (DCs) are located within mucosal sites, such as the 
skin, airways, gut, and decidua. DCs have the unique property of be-
ing able to induce both antigen-specific activation and the immune 
response [53]. DC may also play a role in tolerance induction through 
the generation of T cells with regulatory properties, which in turn 
limit the proliferation of effector T cells or delete antigen-specific T 
cells. Uterine dendritic cells (DCs) within the decidua have been im-
plicated in pregnancy maintenance. DCs serve as antigen-presenting 
cells with the unique ability to induce primary immune responses. 
Just as lymphocytes comprise different subsets, DC subsets that dif-
ferentially control lymphocyte function have been identified. DCs 
may also act to induce immunologic tolerance and regulation of the 
T cell-mediated immunity [54].
Gonadotropins on the immune system
Gonadotropins such as FSH, LH, and hCG are involved in the control 
of the neuroendocrine response crucial for the regulation of the men-
strual cycle, ovulation, and maintenance of the pregnancy. Recent 
studies have reported that, the receptors for FSH, LH, and hCG are ex-
pressed on immune cells and they have capacity to influence the im-
mune response. More specifically, it has been shown that hCG in par-
ticular is able to down-regulate immune responses locally and sys-
temically during pregnancy [55]. The divergent immune-modulatory 
effects of recombinant and urinary-derived FSH, LH, and hCG on hu-
man CD4
+ T cells have been published by Carbone et al. [56]. Recom-
binant FSH (r-FSH) and LH (r-LH) alone showed a modest capacity to 
influence proliferation and cytokine release by CD4
+ T cells. Conver-
sely, their addition to T cells in combination with recombinant hCG 
(r-hCG) induced a powerful down-modulation of T cell proliferation, 
decreased IFN-γ secretion and increased IL-10 production. Thus, the 
authors suggested that the use of the recombinant preparations in 
assisted reproductive techniques might be relevant not only for their 
well-documented endocrine actions but also for their impact on the 
transient immune tolerance known to favor embryo implantation 
and progression of pregnancy.
Summary and conclusion
Endometrial receptivity is commenced by the appropriate expres-
sion of marker molecules, phenotypic changes in endometrial tis-
sues, and the extrusion of pinopodes. These morphological and mo-
lecular changes of endometrial cells occur under the sequential influ-
ence of the sex steroid hormones, estrogen and progesterone. To-
gether with this, successful pregnancy requires strict temporal regu-
lation of maternal immune function to accommodate the semi-allo-
geneic embryo. To prepare for immunological tolerance at the onset 
of implantation, tight temporal regulations are required between the 
immune and endocrine networks. These mechanisms create a favor-
able environment for controlling trophoblast invasion. Steroid hor-
mones have a role in regulating immune regulating functions as well. 
Under the control of sex steroid hormones, immune cells are migrat-
ed and differentiated appropriately. Thus, they affect angiogenesis, 
trophoblast invasion and placentation. Studies on the immunologi-
cal aspects of endometrial receptivity would provide a data to resolve 
reproductive problems such as implantation failure and recurrent 
miscarriages and it would used to be develop controlled ovarian hy-
perstimulation protocols for assisted reproductive techniques. 
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